Maryland Board of Pharmacy Agenda for January 15, 2014--Anticipates publishing new regulations regarding fees for compounding pharmacies on January 24, 2014

REGULATIONS: 10.34.09 Fees and 10.34.19 Sterile Compounding Preparations and Sterile Drug Product Anticipated to be published January 24, 2014.

OTHER MATTERS: Briefing on January 22, 2014 regarding the implementation of the HB 986 State Board of Pharmacy – Sterile Compounding Permits

read entire agenda here

Maryland Board of Pharmacy Meeting Feb. 30, 2012; Agenda Has Been Posted

Board of Pharmacy Meeting Notices

The Next Public Board Meeting: February 20, 2012, 9:30 AM

Location: DHMH Metro Building

Address: 4201 Patterson Avenue
Baltimore, MD 21215

Room:
Agenda: February Agenda 

Date Posted: 02/15/2012
For More Information: (410) 764-3460
dhmh.mdbop@maryland.gov

Maryland Board of Pharmacy December 19, 2012 Agenda Has Numerous Items Relating To Compounding

For example, the agenda list:

REQUESTS FOR RECOMMENDATIONS:
1) November 7, 2012 Meningitis Briefing before HGO – Follow
up for Chairman Hammen
2) Request from Marie Grant for Congressman’s Cummings’ Office
for Board’s views on reporting requirements for pharmacies that
distribute to pharmacies or to distributors and pharmacies.
3) Secretary’s requests Board consideration of 6 additional steps to
ensure safer compounding pharmacies.
Sharfstein request for more action for compounding 121012


And the agenda list the following related to Patient Specific Prescriptions:

Patient Specific Prescriptions - Opthalmic ASC
Draft Board Response – patient specific compounding  - Dulaney
4) Claudia McGrath, Piney Orchard Surgery Center
Prescriptions for compound drugs - Ambulatory Surgery Center
Draft Board Response – patient specific compounding -
Piney
5) Mel Rubin
Compoundingk pharmacies - Mel Rubin
Draft Board Response – patient specific compounding - Rubin

Complete Agenda can be viewed here

Legislators to look at drug shortages Doctors, medical administrators testify at hearing

Andrea K. Walker, The Baltimore Sun

6:57 p.m. EST, December 4, 2012

The staff at Anne Arundel Medical Center considered canceling some surgeries on a recent weekend because the hospital was running low on a common drug used to help bring people out from under anesthesia.

It is the kind of problem hospitals and doctors around the country continue to face as drug shortages that began a few years ago threaten the way everyday medicine is practiced.

The problem has persisted even after calls from Congress and President Barack Obama to find a solution and a federal investigation that found widespread abuses in the drug manufacturing and distribution system. Maryland lawmakers are jumping into the fray with plans to introduce legislation to tackle the issue at the state level.

On Tuesday, the Joint Committee on Health Care Delivery and Finance held a hearing to gather insights on what role the state could play.

Dr. Barry Meisenberg, chair of quality improvement and health systems research at Anne Arundel Medical Center, said the shortages force doctors to make tough decisions on how to treat patients. The hospital decided not to cancel surgeries that weekend, but Meisenberg said the issue was real.

"I used this as an example of how serious this has become," Meisenberg said.

Maryland: Headline mischaracterized Board of Pharmacy's stance

November 26, 2012

On behalf of the Maryland Board of Pharmacy, we are writing to commend Sun reporter Andrea Walker for a fair and honest reflection of information discussed during her interview with board executive director LaVerne Naesea and board commissioner David Chason about the board's monitoring of sterile compounding pharmacies and addressing potential gaps in oversight. The article's on-line headline, "Maryland pharmacy of board says it can adequately monitor compounding pharmacies — Board beefed up standards in recent years" (Nov. 18), accurately indicated the thrust of the interview.

However, as sometimes happens when a story isn't quite spicy enough, an editor may decide to change the headline to increase sales or perhaps raise controversy. The board suspects something like this may have occurred when the referenced article was published on the front page of The Sun's print edition on Monday, Nov. 19, under the headline, "Maryland board resists U.S. role in regulation of pharmacies."

Source found here